Barclays’s GenMark Diagnostics, Inc GNMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-696,710
Closed -$16.7M 4323
2021
Q1
$16.7M Buy
696,710
+672,340
+2,759% +$16.1M 0.01% 673
2020
Q4
$355K Sell
24,370
-7,778
-24% -$113K ﹤0.01% 2477
2020
Q3
$456K Sell
32,148
-5,130
-14% -$72.8K ﹤0.01% 2350
2020
Q2
$548K Sell
37,278
-1,741
-4% -$25.6K ﹤0.01% 2281
2020
Q1
$161K Sell
39,019
-68,497
-64% -$283K ﹤0.01% 2635
2019
Q4
$517K Buy
107,516
+40,787
+61% +$196K ﹤0.01% 2668
2019
Q3
$404K Buy
66,729
+11,330
+20% +$68.6K ﹤0.01% 2719
2019
Q2
$359K Buy
55,399
+40,650
+276% +$263K ﹤0.01% 2898
2019
Q1
$105K Buy
+14,749
New +$105K ﹤0.01% 3319
2018
Q4
Sell
-20,561
Closed -$151K 4562
2018
Q3
$151K Buy
20,561
+14,192
+223% +$104K ﹤0.01% 3205
2018
Q2
$40K Sell
6,369
-4,249
-40% -$26.7K ﹤0.01% 3371
2018
Q1
$58K Buy
10,618
+2,532
+31% +$13.8K ﹤0.01% 3450
2017
Q4
$34K Buy
8,086
+6,905
+585% +$29K ﹤0.01% 3507
2017
Q3
$11K Buy
1,181
+1,148
+3,479% +$10.7K ﹤0.01% 3412
2017
Q2
$0 Sell
33
-1,943
-98% ﹤0.01% 4187
2017
Q1
$25K Sell
1,976
-997
-34% -$12.6K ﹤0.01% 3313
2016
Q4
$36K Buy
2,973
+2,416
+434% +$29.3K ﹤0.01% 2934
2016
Q3
$7K Buy
557
+496
+813% +$6.23K ﹤0.01% 3360
2016
Q2
$1K Sell
61
-1,776
-97% -$29.1K ﹤0.01% 3505
2016
Q1
$9K Buy
+1,837
New +$9K ﹤0.01% 2961
2015
Q4
Sell
-1,442
Closed -$11K 3934
2015
Q3
$11K Buy
1,442
+636
+79% +$4.85K ﹤0.01% 3051
2015
Q2
$7K Sell
806
-447
-36% -$3.88K ﹤0.01% 3476
2015
Q1
$15K Sell
1,253
-5,917
-83% -$70.8K ﹤0.01% 3230
2014
Q4
$93K Buy
7,170
+5,734
+399% +$74.4K ﹤0.01% 2740
2014
Q3
$11K Sell
1,436
-914
-39% -$7K ﹤0.01% 3693
2014
Q2
$31K Buy
2,350
+942
+67% +$12.4K ﹤0.01% 3254
2014
Q1
$13K Sell
1,408
-529
-27% -$4.88K ﹤0.01% 3709
2013
Q4
$25K Buy
1,937
+520
+37% +$6.71K ﹤0.01% 3652
2013
Q3
$17K Sell
1,417
-113
-7% -$1.36K ﹤0.01% 3530
2013
Q2
$16K Buy
+1,530
New +$16K ﹤0.01% 3763